GLP-3 (R)
Research OnlyStrong EvidenceRetatrutide — GLP-1/GIP/Glucagon Triple Agonist
Vendor shorthand for Retatrutide — the first triple incretin agonist with ~24% weight loss in Phase II trials.
Half-Life
~6 days
Molecular Weight
~5000 g/mol
GLP-3 (R) is a vendor shorthand for Retatrutide, where 'R' refers to Retatrutide. The 'GLP-3' in the vendor designation is a shorthand code — retatrutide is a triple agonist of GLP-1R, GIPR, and glucagon receptor (GCGR). Not FDA-approved; in Phase III clinical trials. Phase II NEJM data: 24.2% mean weight reduction at 48 weeks — the highest ever reported. See Retatrutide profile for full details.
Also Known As
GLP-3 RRetatrutideLY3437943
Amino Acid Sequence
Proprietary Eli Lilly GLP-1/GIP/GCG hybrid peptide
Reconstitution
Research peptide: reconstitute with bacteriostatic water. Extremely potent — precise dosing essential.
Open Reconstitution Calculator →